Celvive Inc entered the industry of Medical Research in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Hatem Sabaawy by calling (908) 731-6610 during business hours. You can also write to the business’ Single Location at 120 Albany St # 850, New Brunswick, New Jersey NJ 08901. You can also visit the company’s website at foundationventure.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Celvive Inc |
| Representative: | Hatem Sabaawy |
| Place of Business: | 120 Albany St # 850, New Brunswick, NJ 08901 |
| Contact Number: | (908) 731-6610 |
| Website: | foundationventure.com |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2012 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Celvive Inc is a company operating from Middlesex, New Jersey providing professional Medical Research and relevant B2B variables. It was founded in 2012 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Celvive Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Hatem Sabaawy at (908) 731-6610 for related queries, or to locate its Single Location using the coordinates 40.49643,-74.444823.
The Single Location can also be found at the street address 120 Albany St # 850 in New Brunswick, New Jersey 08901 and can be engaged online through the company website at foundationventure.com, the company Twitter , and Facebook page .